1. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
   Shinya Matsuzaki et al, 2015, Cancer Cell International CrossRef
2. Novel Anti-angiogenic Therapies Using Naturally Occurring and Synthetic Drugs to Combat Progestin-Dependent Breast Cancer
   Salman M. Hyder et al, 2013, Cell and Molecular Biology of Breast Cancer CrossRef
3. Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells
   Li-li Hou et al, 2013, Acta Pharmacologica Sinica CrossRef
4. Targeting DNA repair and replication stress in the treatment of ovarian cancer
   Junko Murai, 2017, International Journal of Clinical Oncology CrossRef
5. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival
   Feng Zhou et al, 2014, Clinical Chemistry and Laboratory Medicine CrossRef
6. SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway
   X Peng et al, 2014, Cell Death & Disease CrossRef
7. Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53
   SEE-HYOUN G PARK et al, 2014, International Journal of Oncology CrossRef
8. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer
   Jianling Bi et al, 2022, Cell Death & Disease CrossRef
9. A review on hepatocyte nuclear factor-1beta and tumor
   Dan-Dan Yu et al, 2015, Cell & Bioscience CrossRef
10. A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer
    Harsh B. Pathak et al, 2015, PLOS ONE CrossRef
11. Hepatocyte nuclear factor 1 beta: A perspective in cancer
    Shubhra Chandra et al, 2021, Cancer Medicine CrossRef
12. An association of iNKT+/CD3+/CD161+ lymphocytes in ovarian cancer tissue with CA125 serum concentration
    Izabela Winkler et al, 2020, Immunobiology CrossRef
13. Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2/Akt/FOXO3 pathway in ovarian cancer cells
    Jun Sang Bae et al, 2017, Oncology Reports CrossRef